Alzheimer's Biomarker Tests Development

11. September 2025 Von KI berichtet

Regulatory developments were noted for blood-based biomarker tests to detect Alzheimer's disease. These tests represent an emerging tool for early diagnosis. The update was part of a health innovation brief.

Japanese researchers identify biological cause of long COVID brain fog

Scientists in Japan have discovered a key molecular change behind the brain fog experienced by many long COVID patients. Using advanced brain imaging, they found increased density of AMPA receptors linked to cognitive impairment. The findings, published on October 1, 2025, could lead to new diagnostics and treatments.

Blood test identifies Parkinson's years before symptoms

Scientists have developed a blood-based test that detects Parkinson's disease up to seven years before the onset of symptoms. The test targets abnormal alpha-synuclein proteins and shows high accuracy in at-risk individuals. This breakthrough could enable earlier treatments to slow disease progression.

FDA Approves Drug for Autoimmune Neuropathies

13. September 2025 Von KI berichtet

The FDA approved a new drug for treating autoimmune neuropathies on September 9, 2025, accompanied by discoveries of new autoantibodies and effective complement inhibitors. This development ends 30 years of limited treatment progress in the field.